Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 9,021–9,040 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Calcium Gluconate 1% Eyewash Oph. Soln, 10 mg/mL, 1000 mL bottles, Pharm D Solutions, Houston, Texas ---- NDC 69699-0907-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Caffeine and Sodium Benzoate Injection 125 mg/125 mg/mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-1428-02

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Bi-Mix (Papaverine/Phentolamine 150 mg/5 mg) a) Injectable NDC 69699-1760-15; b) (LYO) Powder NDC 69699-1760-15, Pharm D Solutions, Houston, Texas

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Bi-Mix Injection (Alprostadil 80 mcg/Lidocaine 2 mg/mL) Pharm D Solutions, Houston, Texas --- NDC 69699-1317-03

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Bi-Mix Injection, (Alprostadil 40 mcg/Lidocaine 2 mg/mL) Pharm D Solutions, Houston, Texas --- NDC 69699-1305-03

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Bi-Mix Injection (Alprostadil 150 mcg/Lidocaine 2 mg/mL), Pharm D Solutions, Houston, Texas --- NDC 69699-1323-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Bacteriostatic Water for Injection 10 mL, Pharm D Solutions, Houston, Texas --- NDC 69699-1417-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Beta-complex B-1, B-6, B-3, B-12, B-5 100, 2.54 Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1611-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Ascorbic Acid 500 mg/mL Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1502-50

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Arginine Injections 100 mcg/mL, Pharm D Solutions, Houston, Texas NDC 69699-1414-20

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Acetylcysteine Injection 10 mg/5 mL (2 mg/mL), Pharm D Solutions, Houston, Texas ---- NDC 69699-1424-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine 30 mg added to NS 250 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38

by Avella of Deer Valley, Inc. Store 38

Reason
Lack of assurance of sterility
Recall initiated
October 19, 2018
Reported by FDA
November 7, 2018
Distribution
U.S.A. nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine 25 mg added to NS 250 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38

by Avella of Deer Valley, Inc. Store 38

Reason
Lack of assurance of sterility
Recall initiated
October 19, 2018
Reported by FDA
November 7, 2018
Distribution
U.S.A. nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Hydromorphone (0.2 mg/mL) in NS 100 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38

by Avella of Deer Valley, Inc. Store 38

Reason
Lack of assurance of sterility
Recall initiated
October 19, 2018
Reported by FDA
November 7, 2018
Distribution
U.S.A. nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Fentanyl (10 mcg/mL) in NS 1 mL (in 3mL BD Syringe), Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38

by Avella of Deer Valley, Inc. Store 38

Reason
Lack of assurance of sterility
Recall initiated
October 19, 2018
Reported by FDA
November 7, 2018
Distribution
U.S.A. nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Morphine (1 mg/mL) in NS 100 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38

by Avella of Deer Valley, Inc. Store 38

Reason
Lack of assurance of sterility
Recall initiated
October 19, 2018
Reported by FDA
November 7, 2018
Distribution
U.S.A. nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01

by Boehringer Ingelheim Pharmaceuticals, Inc.

Reason
Failed Dissolution Specifications: OOS resultsduring routine stability testing
Recall initiated
October 22, 2018
Reported by FDA
November 7, 2018
Distribution
Distributed nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Irbesartan Bulk Active Pharmaceutical Ingredient.

by Aurobindo Pharma Limited (Unit I)

Reason
CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.
Recall initiated
October 24, 2018
Reported by FDA
November 7, 2018
Distribution
Product was distributed to one customer in NY.

View recall →

Drug Recall Terminated Historical recordClass II

Diet Power, Homeopathic Oral Spray 1.38 fl. oz. (41 mL). Manufactured by Sprayology Gaithersburg, MD 20879. NDC 61096-0004-1

by Sprayology

Reason
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Recall initiated
October 9, 2018
Reported by FDA
November 7, 2018
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Body Balance, Homeopathic Oral Spray 1.38 fl. oz (41 mL). Manufactured by Sprayology Gaithersburg, MD 20879. NDC 61096-0039-1

by Sprayology

Reason
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Recall initiated
October 9, 2018
Reported by FDA
November 7, 2018
Distribution
Distributed Nationwide in the USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.